ArticleMedicine2026
Differential correlation patterns of serum prolactin and total antioxidant status in obstructive sleep apnea: A cross-sectional study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obstructive sleep apnea (OSA) severity classification relies primarily on the Apnea-Hypopnea Index (AHI), which quantifies event frequency but does not capture event duration or hypoxemic burden. We examined whether serum prolactin and total antioxidant status (TAS) show differential correlation patterns with frequency- versus duration-based polysomnographic parameters, potentially reflecting distinct pathophysiological mechanisms. This cross-sectional study enrolled 55 participants (controls: n = 12, AHI < 5; mild/moderate OSA: n = 22, 5 ≤ AHI < 30; severe OSA: n = 21, AHI ≥ 30) undergoing overnight polysomnography. Fasting serum prolactin and TAS were measured. Spearman correlations examined biomarker associations with AHI (numerically equivalent to the Respiratory Disturbance Index in this cohort), oxygen desaturation index, total apnea-hypopnea duration, longest apnea duration, and lowest oxygen saturation; P-values were adjusted for multiple testing using the Benjamini-Hochberg false discovery rate procedure. Both prolactin (22.7 ± 9.8 vs 14.7 ± 7.2 vs 12.7 ± 7.3 ng/mL, P = .007) and TAS (1.181 ± 0.068 vs 1.122 ± 0.065 vs 1.111 ± 0.057 mmol/L, P = .021) decreased progressively across severity groups. TAS correlated with event frequency (AHI: r = -0.419, q = 0.013) but not with longest apnea duration (r = -0.223, q = 0.103), while prolactin correlated with both frequency (AHI: r = -0.360, q = 0.017) and duration parameters (longest apnea duration: r = -0.288, q = 0.044). However, when TAS and prolactin correlations were compared directly for each parameter using Steiger Z test for dependent correlations, none of the differences reached statistical significance (all P ≥ .65), indicating that this apparent divergence reflects differing significance thresholds rather than a formally confirmed difference in association strength. A positive correlation between prolactin and lowest oxygen saturation did not retain significance after false discovery rate correction (q = 0.053) and is considered exploratory. TAS and prolactin show descriptively different correlation patterns with frequency- and duration-based polysomnographic parameters; however, direct statistical comparison did not confirm these differences as significant, and the findings should be regarded as hypothesis-generating rather than confirmed evidence of distinct pathophysiological mechanisms. Larger, independent cohorts are needed to formally test whether these biomarkers diverge in their associations with OSA severity dimensions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.